AIxMed
About:
AIxMed helps pathologists to digitize 3D cytology samples in minutes and extract clinical insights in seconds.
Website: https://www.aixmed.com/
Top Investors: Taiwania Capital Management Corporation
Description:
AIxMed helps pathologists to digitize 3D cytology samples in minutes and extract clinical insights in seconds. The company was founded in 2018 and is headquartered in Santa Clara, California, United States.
Total Funding Amount:
$11M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Santa Clara, California, United States
Founded Date:
2018-06-01
Founders:
Samuel Chen, Tien-Jen Liu
Number of Employees:
11-50
Last Funding Date:
2023-04-27
IPO Status:
Private
© 2024 MyAiNote.com